Moreover, a diminished response to oxidative stress participates in the development of neurodegenerative diseases like Parkinson’s disease (PD) [139], whereas amyloid ß and tau, two proteins associated with Alzheimer’s disease (AD), may be modified by glycosylation with PPP-derived D-ribose [138]. This evidence concerns the gene MAPT and Parkinson disease.